1. Home
  2. POCI vs GBIO Comparison

POCI vs GBIO Comparison

Compare POCI & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POCI
  • GBIO
  • Stock Information
  • Founded
  • POCI 1982
  • GBIO 2016
  • Country
  • POCI United States
  • GBIO United States
  • Employees
  • POCI N/A
  • GBIO N/A
  • Industry
  • POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • POCI Health Care
  • GBIO Health Care
  • Exchange
  • POCI Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • POCI 32.4M
  • GBIO 29.2M
  • IPO Year
  • POCI N/A
  • GBIO 2020
  • Fundamental
  • Price
  • POCI $4.32
  • GBIO $0.38
  • Analyst Decision
  • POCI
  • GBIO Strong Buy
  • Analyst Count
  • POCI 0
  • GBIO 4
  • Target Price
  • POCI N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • POCI 32.7K
  • GBIO 476.6K
  • Earning Date
  • POCI 05-15-2025
  • GBIO 05-07-2025
  • Dividend Yield
  • POCI N/A
  • GBIO N/A
  • EPS Growth
  • POCI N/A
  • GBIO N/A
  • EPS
  • POCI N/A
  • GBIO N/A
  • Revenue
  • POCI $17,626,155.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • POCI N/A
  • GBIO N/A
  • Revenue Next Year
  • POCI N/A
  • GBIO N/A
  • P/E Ratio
  • POCI N/A
  • GBIO N/A
  • Revenue Growth
  • POCI N/A
  • GBIO 146.47
  • 52 Week Low
  • POCI $3.47
  • GBIO $0.32
  • 52 Week High
  • POCI $6.90
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • POCI 47.11
  • GBIO 45.45
  • Support Level
  • POCI $4.10
  • GBIO $0.37
  • Resistance Level
  • POCI $4.68
  • GBIO $0.41
  • Average True Range (ATR)
  • POCI 0.33
  • GBIO 0.03
  • MACD
  • POCI -0.02
  • GBIO 0.00
  • Stochastic Oscillator
  • POCI 28.30
  • GBIO 28.93

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: